The effect of oral hydralazine on circulating human cholesterol

H M PERRY Jr et al. Am J Med Sci. 1962 May.

. 1962 May:243:564-73.

doi: 10.1097/00000441-196205000-00003.

No abstract available

Similar articles

Clinical evaluation of the antihypertensive effect of metoprolol in combination with hydrochlorothiazide and hydralazine in an unselected hypertensive population.
Tuomilehto J, Nissinen A, Honkavaara M. Tuomilehto J, et al. Acta Cardiol. 1980;35(4):289-301. Acta Cardiol. 1980. PMID: 7010854 Clinical Trial.
Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit.
Blumlein SL, Sievers R, Kidd P, Parmley WW. Blumlein SL, et al. Am J Cardiol. 1984 Oct 1;54(7):884-9. doi: 10.1016/s0002-9149(84)80226-x. Am J Cardiol. 1984. PMID: 6486041
Myocardial metabolic effects of in vivo hydralazine treatment of streptozotocin-diabetic rats.
Burns AH, Burns LA, Jurenka LU, Summer WR. Burns AH, et al. Am J Physiol. 1991 Feb;260(2 Pt 2):H516-21. doi: 10.1152/ajpheart.1991.260.2.H516. Am J Physiol. 1991. PMID: 1996694
[DRUG THERAPY OF CIRCULATORY DISEASES].
TAKATSU T. TAKATSU T. Naika. 1964 Mar;13:465-79. Naika. 1964. PMID: 14125381 Review. Japanese. No abstract available.
Prazosin: a review of clinical experience in hypertension.
Packard RS. Packard RS. Ther Umsch. 1981;38 Suppl:28-32. Ther Umsch. 1981. PMID: 6122285 Review. No abstract available.

[Antihypertensive therapy and lipid metabolism].
Krone W, Müller-Wieland D, Greten H. Krone W, et al. Klin Wochenschr. 1984 Mar 1;62(5):193-202. doi: 10.1007/BF01721044. Klin Wochenschr. 1984. PMID: 6143851 Review. German.
Antihypertensive therapy, serum lipids, coronary heart disease and hypertension--balancing the risks and benefits of treatment.
Houston MC. Houston MC. West J Med. 1986 Aug;145(2):219-21. West J Med. 1986. PMID: 3765601 Free PMC article. No abstract available.